126 related articles for article (PubMed ID: 27146272)
21. The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium.
Okin PM; Kjeldsen SE; Lindholm LH; Dahlöf B; Devereux RB
Blood Press; 2012 Jun; 21(3):146-52. PubMed ID: 22243363
[TBL] [Abstract][Full Text] [Related]
22. Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study.
Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
Am J Hypertens; 2012 Oct; 25(10):1101-9. PubMed ID: 22717544
[TBL] [Abstract][Full Text] [Related]
23. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
[TBL] [Abstract][Full Text] [Related]
24. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Okin PM; Devereux RB; Nieminen MS; Jern S; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Dahlöf B;
Circulation; 2006 Jan; 113(1):67-73. PubMed ID: 16365195
[TBL] [Abstract][Full Text] [Related]
25. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
26. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
27. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
Ishikawa J; Yamanaka Y; Watanabe S; Toba A; Harada K
Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
[TBL] [Abstract][Full Text] [Related]
28. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
[TBL] [Abstract][Full Text] [Related]
29. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
30. Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study.
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Eur J Heart Fail; 2011 Apr; 13(4):384-91. PubMed ID: 21239405
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
32. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
[TBL] [Abstract][Full Text] [Related]
33. Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: A meta-analysis.
Yi S; Wang F; Wan M; Yi X; Zhang Y; Sun S
J Electrocardiol; 2020; 61():27-31. PubMed ID: 32504899
[TBL] [Abstract][Full Text] [Related]
34. Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment.
Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
Blood Press; 2014 Apr; 23(2):71-80. PubMed ID: 23721506
[TBL] [Abstract][Full Text] [Related]
35. In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.
Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Lindholm LH; Dahlöf B;
Hypertension; 2007 Nov; 50(5):984-90. PubMed ID: 17893425
[TBL] [Abstract][Full Text] [Related]
36. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
[TBL] [Abstract][Full Text] [Related]
37. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
Mahn JJ; Dubey E; Brody A; Welch R; Zalenski R; Flack JM; Ference B; Levy PD
Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
[TBL] [Abstract][Full Text] [Related]
39. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
[TBL] [Abstract][Full Text] [Related]
40. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
